VELAVIGO
VelaVigo is a start-up company engaged in macromolecular biopharmaceuticals.
VELAVIGO
Industry:
Biopharma Biotechnology Health Care Therapeutics
Founded:
2021-01-01
Address:
Shanghai, Shanghai, China
Country:
China
Website Url:
http://www.velavigo.com
Status:
Active
Total Funding:
50 M USD
Technology used in webpage:
Chinese Server Location
Similar Organizations
Alpha Biopharma
Alpha Biophama is a clinical stage biopharmaceutical company.
AnnGeen
AnnGeen has comprehensively deployed the field of molecular diagnosis of genetic diseases.
Anthos Therapeutics
Anthos Therapeutics is a biopharmaceutical company that specializes in the treatment of cardiovascular and metabolic diseases.
Akashi Therapeutics
Akashi Therapeutics is a clinical stage biopharmaceutical company.
HighTide Therapeutics
HighTide Therapeutics is a global clinical-stage biopharmaceutical company.
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
Vitalgen
Vitalgen is a biopharmaceutical company that focuses on the research and development of gene therapeutics.
Investors List
Med-Fine Capital
Med-Fine Capital investment in Seed Round - VelaVigo
Honghui Capital
Honghui Capital investment in Angel Round - VelaVigo
Vertex Ventures China
Vertex Ventures China investment in Angel Round - VelaVigo
Sany Innovation Investment
Sany Innovation Investment investment in Angel Round - VelaVigo
Panacea Venture
Panacea Venture investment in Angel Round - VelaVigo
Power Capital
Power Capital investment in Angel Round - VelaVigo
Official Site Inspections
http://www.velavigo.com Semrush global rank: 9.81 M Semrush visits lastest month: 311
Unable to get host informations!!!
More informations about "VelaVigo"
VelaVigo - Crunchbase Company Profile & Funding
Organization. VelaVigo . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. ... VelaVigo is a start-up company engaged in macromolecular biopharmaceuticals. Products and …See details»
VelaVigo
关于橙帆医药 一家具有强大研发心脏的 生物医药创新企业. 千帆竞渡，星辰大海。橙帆医药（VelaVigo）成立于2021年10月，由行业资深科学家创立，是一家立足于中国，面向全球的 …See details»
VelaVigo - Company Profile - Tracxn
Dec 1, 2024 Media has covered VelaVigo for a total of 2 events in the last 1 year, 1 of them has been about company updates. Avenzo Therapeutics Provides Corporate Update and …See details»
VelaVigo - LinkedIn
VelaVigo was founded by Dr. Jing Li, a renowned biopharma executive, in October 2021. We leverage discovery as an innovative engine with an emphasis on novel technologies, including …See details»
VelaVigo - Funding, Financials, Valuation & Investors - Crunchbase
VelaVigo is a start-up company engaged in macromolecular biopharmaceutical. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. Pricing. ...See details»
VelaVigo - Contacts, Employees, Board Members, Advisors & Alumni
VelaVigo is a start-up company engaged in macromolecular biopharmaceutical. Unlock even more features with Crunchbase ProSee details»
VelaVigo - BIO International Convention 2024
Jun 3, 2024 VelaVigo was founded by Dr. Jing Li, a renowned biopharma executive, in October 2021. We leverage discovery as an innovative engine with an emphasis on novel …See details»
VelaVigo - Products, Competitors, Financials, Employees, …
VelaVigo is a drug research and development enterprise. Use the CB Insights Platform to explore VelaVigo's full profile. VelaVigo - Products, Competitors, Financials, Employees, Headquarters …See details»
VelaVigo (Shanghai) Ltd. - Drug pipelines, Patents, Clinical trials ...
Nov 1, 2024 Explore VelaVigo (Shanghai) Ltd. with its drug pipeline, therapeutic area, technology platform, 2 literature, Disease Domain:Neoplasms, Technology Platform:Antibody …See details»
VelaVigo - A Panacea Venture Portfolio Company
VelaVigo was incubated by Panacea and was founded by Dr. Jing Li, the former head of early-stage discovery at WuXi Biologics. Dr. Li successfully led over 200 discovery programs during …See details»
Velavigo Asset Profile | Preqin
Established in 2021 and based in Shanghai, China, Velavigo is a health care company that focuses on research and development of biomedicine. The founder, chairman and CEO (Chief …See details»
VelaVigo - Drug pipelines, Patents, Clinical trials - Synapse - Patsnap
Nov 1, 2024 100 Translational Medicine associated with VelaVigo. Login to view more data. Corporation Tree. Boost your research with our corporation tree data. login. or. view full …See details»
VelaVigo - Crunchbase
VelaVigo is a start-up company engaged in macromolecular biopharmaceutical.See details»
VelaVigo
SHANGHAI and BOSTON, Nov. 18, 2024 -- VelaVigo Cayman Limited (VelaVigo), a biotech company focusing on discovery and development of multi-specific antibodies and antibody …See details»
Newsroom - VelaVigo
Oct 15, 2021 VelaVigo Closed $50M Angel Round Financing . On November 15, 2021, VelaVigo, a Shanghai-based biotech company focused on globally innovative large molecule …See details»
VelaVigo Announces Exclusive Option Agreement with Avenzo to …
Nov 18, 2024 VelaVigo was founded in 2021 with a $50M investment, with its global R&D headquarters in Shanghai, and clinical and US operations in Boston. For more information, …See details»
With $50M angel round, WuXi vet Li sets sail with own venture
Nov 15, 2021 After eight years of developing compounds at WuXi Biologics for the company’s clients, Jing Li now has $50 million in angel money to create his own pipeline of multi-specifics …See details»
VelaVigo - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Nov 1, 2024 VelaVigo is a start-up company engaged in macromolecular biopharmaceutical. Start Free Trial . Chrome ExtensionSee details»
VelaVigo: Li, Zhang chart course to build global biologics player
Jan 8, 2022 Founded in October 2021, VelaVigo (Shanghai) Ltd. — the name is a play on the Latin terms for sailing and navigation — plans to discover, develop and commercialize …See details»
VelaVigo Announces Exclusive Option Agreement with Avenzo to …
VelaVigo will retain rights for the Greater China region and plans to collaborate with Avenzo for global development of the bispecific ADC; VelaVigo’s pipeline includes over ten first-in-class …See details»